Table 9

Effect of IDCT use in AQIP compared to UQIP*.

Estimate

StdErr

P-value

HbA1c (%)

0.0848

0.1476

0.5656

SBP (mm Hg)

2.3901

2.2566

0.2896

DBP (mm Hg)

0.4532

1.3308

0.7335

T. Chol (mg/dl)

1.8074

5.379

0.7369

LDL-CL (mg/dl)

0.1833

4.686

0.9688

HDL-C (mg/dl)

-1.4947

1.4404

0.2995

BMI

0.0092

0.2799

0.9737

Targets (%)

-0.3404

0.4078

0.4039

Non smoker (%)

1.0710

1.3691

0.4341

Health diet (%)

0.4817

0.6984

0.4904

Physical exercise (%)

1.0129

0.6550

0.1221

Aspirin/clopidogrel (%)

1.3368

0.5702

0.0119

ACE/A2A treatment (%)

1.4285

0.7558

0.0584

Statin treatment (%)

0.2726

0.6341

0.1766

* Reported estimates represent the difference of the effect of IDCT use on each outcome in the AQIP group and the effect of IDCT use in the UQIP group.

Borgermans et al. BMC Health Services Research 2009 9:179   doi:10.1186/1472-6963-9-179